3',5'-O-(1,1,3,3-tetraisopropyldisilox-1,3-diyl)-tubercidin | 85335-76-8

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 3',5'-O-(1,1,3,3-tetraisopropyldisilox-1,3-diyl)-tubercidin
• 英文别名: 7-[3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-β-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine；(6aR,8R,9R,9aS)-8-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-2,2,4,4-tetra(propan-2-yl)-6a,8,9,9a-tetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-9-ol
• CAS: 85335-76-8
• 化学式: C₂₃H₄₀N₄O₅Si₂
• 分子量: 508.765
• InChiKey: JVAUVFXWBMNOCS-GLHSZLCASA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.23
• 重原子数：
  34
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.74
• 拓扑面积：
  114
• 氢给体数：
  2
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  3',5'-O-(1,1,3,3-tetraisopropyldisilox-1,3-diyl)-tubercidin 在 4-二甲氨基吡啶 、 偶氮二异丁腈 、 三正丁基氢锡 作用下， 以 甲苯 、 乙腈 为溶剂， 生成 7-((6aR,8R,9aS)-2,2,4,4-tetraisopropyltetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
  参考文献：
  名称：

  Nucleic acid related compounds. 42. A general procedure for the efficient deoxygenation of secondary alcohols. Regiospecific and stereoselective conversion of ribonucleosides to 2'-deoxynucleosides

  摘要：

  DOI：

  10.1021/ja00350a052
• 作为产物：
  描述：

  1,1,3,3-tetraisopropyldisiloxane 在 吡啶 、 氯 作用下， 以 四氯化碳 为溶剂， 反应 0.5h， 生成 3',5'-O-(1,1,3,3-tetraisopropyldisilox-1,3-diyl)-tubercidin
  参考文献：
  名称：

  Nucleic acid related compounds. 42. A general procedure for the efficient deoxygenation of secondary alcohols. Regiospecific and stereoselective conversion of ribonucleosides to 2'-deoxynucleosides

  摘要：

  DOI：

  10.1021/ja00350a052

文献信息

• [EN] OLIGONUCLEOTIDES HAVING MODIFIED NUCLEOSIDE UNITS<br/>[FR] OLIGONUCLEOTIDES A UNITES NUCLEOSIDIQUES MODIFIEES
  申请人：ISIS PHARMACEUTICALS INC

  公开号：WO2003099840A1

  公开（公告）日：2003-12-04

  Disclosed are oligonucleotides and oligonucleosides that include one or more modified nucleoside units. The oligonucleotides and oligonucleosides are particularly useful as antisense agents, ribozymes, aptamer, siRNA agents, probes and primers or, when hybridized to an RNA, as a substrate for RNA cleaving enzymes including RNase H and dsRNase.

  揭示了包含一个或多个修饰核苷酸单元的寡核苷酸和寡核苷苷。这些寡核苷酸和寡核苷苷特别适用作为反义物质、核酶、适配体、siRNA物质、探针和引物，或者在与RNA杂交时，作为RNA裂解酶（包括RNase H和dsRNase）的底物。
• 2' And 3'-ketonucleosides and their arabino and xylo reduction products
  作者：Fritz Hansske、Danuta Madej、Morris J. Robins

  DOI：10.1016/0040-4020(84)85111-x

  日期：1984.1

  A number of 2',5'- or 3',5'-diprotected ribonucleosides and 5'-protected 2'- or 3'-deoxy-β-D-erythro-pentofuranosyl nucleosides have been oxidized to the corresponding 3' or 2'-ketonucleoside derivatives using chromium trioxide/pyridine/acetic anhydride or dimethyl sulfoxide/ acetic anhydride. Reduction of the carbonyl functions with sodium borohydride gave the inverted arabino, xylo, or deoxy-threo

  许多2'，5'-或3'，5'-双保护核糖核苷和5'-保护的2'-或3'-脱氧-β-D-赤型-戊呋喃糖基核苷已被氧化为相应的3'或2使用三氧化铬/吡啶/乙酸酐或二甲基亚砜/乙酸酐的'-酮核苷衍生物。用硼氢化钠还原羰基官能团，可以通过在糖环的受阻较少的α面上进行攻击，使倒位的阿拉伯糖，木糖或脱氧苏糖异构体成为主要产物。通过证明已经发生了原始羟基的完全氧化，使用硼氢化氘化钠的平行还原证实了差向异构体比率。氘标记还有助于进行NMR 频谱分配。
• NUCLEOSIDE DERIVATIVES AS INHIBITORS OF RNA-DEPENDENT RNA VIRAL POLYERMASE
  申请人：MERCK SHARP & DOHME CORP.

  公开号：US20170183373A1

  公开（公告）日：2017-06-29

  The present invention provides nucleoside compounds and certain derivatives thereof which are inhibitors of RNA-dependent RNA viral polymerase. These compounds are inhibitors of RNA-dependent RNA viral replication and are useful for the treatment of RNA-dependent RNA viral infection. They are particularly useful as inhibitors of hepatitis C virus (HCV) NS5B polymerase, as inhibitors of HCV replication, and/or for the treatment of hepatitis C infection. The invention also describes pharmaceutical compositions containing such nucleoside compounds alone or in combination with other agents active against RNA-dependent RNA viral infection, in particular HCV infection. Also disclosed are methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection with the nucleoside compounds of the present invention.

  本发明提供了核苷类化合物及其某些衍生物，这些化合物是RNA依赖性RNA病毒聚合酶的抑制剂。这些化合物是RNA依赖性RNA病毒复制的抑制剂，对于治疗RNA依赖性RNA病毒感染非常有用。它们特别适用于作为乙型肝炎病毒（HCV）NS5B聚合酶的抑制剂，作为HCV复制的抑制剂，和/或用于治疗丙型肝炎感染。该发明还描述了含有这种核苷类化合物的药物组合物，单独使用或与其他针对RNA依赖性RNA病毒感染，特别是HCV感染的药物一起使用。还公开了使用本发明的核苷类化合物抑制RNA依赖性RNA聚合酶、抑制RNA依赖性RNA病毒复制和/或治疗RNA依赖性RNA病毒感染的方法。
• Nucleic acid related compounds. 74. Synthesis and biological activity of 2'(and 3')-deoxy-2'(and 3')-methylenenucleoside analogs that function as mechanism-based inhibitors of S-adenosyl-L-homocysteine hydrolase and/or ribonucleotide reductase
  作者：Morris J. Robins、Vicente Samano、Weijian Zhang、Jan Balzarini、Erik De Clercq、Ronald T. Borchardt、Younha Lee、Chong Sheng Yuan

  DOI：10.1021/jm00090a020

  日期：1992.6

  with TBDMS chloride/imidazole/DMF gave a separable mixture of 5'-O, 2',5'-bis-O (22), 3',5'-bis-O (23), and 2',3',5'-tris-O-TBDMS derivatives. Oxidation of 22 and 23 with CrO3/pyridine/Ac2O, treatment of the respective ketonucleosides with methylenetriphenylphosphorane, and deprotection gave 2-amino-6-chloro-9-[3(and 2)-deoxy-3(and 2)-methylene- beta-D-erythro-pentofuranosyl]purines (28 and 37) that

  用TBDMS氯化物/咪唑/ DMF处理2-氨基-6-氯-9-（β-D-呋喃呋喃糖基）嘌呤（21）得到5'-O，2'，5'-bis-O的可分离混合物（ 22），3'，5'-bis-O（23）和2'，3'，5'-tris-O-TBDMS衍生物。用CrO3 /吡啶/ Ac2O氧化22和23，用亚甲基三苯基膦烷处理各个酮核苷，并脱保护得到2-氨基-6-氯-9- [3（和2）-脱氧-3（和2）-亚甲基- β-D-赤型-五呋喃糖基]嘌呤（28和37）被转化为其他2-氨基-6-取代的嘌呤类似物。通过类似的方法，将结核菌素转化为2'-脱氧-2'-亚甲基tubercidin（49）。研究了2'-和3'-亚甲基腺苷类似物对S-腺苷-L-高半胱氨酸水解酶的灭活作用。
• 2'-methoxy substituted oligomeric compounds and compositions for use in gene modulations
  申请人：——

  公开号：US20040147022A1

  公开（公告）日：2004-07-29

  Compositions comprising first and second oligomers are provided wherein at least a portion of the first oligomer is capable of hybridizing with at least a portion of the second oligomer, at least a portion of the first oligomer is complementary to and capable of hybridizing to a selected target nucleic acid, and at least one of the first or second oligomers includes a modified sugar and/or backbone modification. In some embodiments the modification is a 2′-OCH 3 substituent group on a sugar moiety. Oligomer/protein compositions are also provided comprising an oligomer complementary to and capable of hybridizing to a selected target nucleic acid and at least one protein comprising at least a portion of an RNA-induced silencing complex (RISC), wherein at least one nucleotide of the oligomer has a modified sugar and/or backbone modification.

  提供了包含第一和第二寡核苷酸的组合物，其中第一寡核苷酸的至少一部分能够与第二寡核苷酸的至少一部分杂交，第一寡核苷酸的至少一部分与所选目标核酸互补并能够杂交，第一或第二寡核苷酸中至少有一个包含修饰糖和/或骨架修饰。在某些实施例中，修饰是在糖基上的2'-OCH3取代基。还提供了寡核苷酸/蛋白质组合物，其中包括与所选目标核酸互补并能够杂交的寡核苷酸和至少一种蛋白质，该蛋白质包括RNA诱导沉默复合物（RISC）的至少一部分，其中至少一核苷酸具有修饰糖和/或骨架修饰。